Oncology Medical News about Lymphoma Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Protein kinase C-beta II expression in diffuse large B-cell lymphoma predicts for inferior outcome of anthracycline-based chemotherapy with and without rituximab
Leukemia and Lymphoma, 10/30/09

Chaiwatanatorn K et al. – Immunohistochemically demonstrated PKC–beta II expression thus identified patient subgroups where alternative treatment strategies may confer superior outcome. PKC–beta II expression has prognostic significance not only for CHOP therapy in low–risk IPI disease, but also for all patients receiving CHOP plus rituximab.

<< Previous
High rate of survival in transformed lymphoma after autologous...

Next >>
A prospective study of left ventricle function after treatment...

Influence of low absolute lymphocyte count of patients with nongerminal center type diffuse large B-cell lymphoma with R-CHOP therapy
Annals of Oncology, 11/16/09 Relevance Score: 98%

Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma
Leukemia and Lymphoma, 11/04/09 Relevance Score: 98%

High rate of survival in transformed lymphoma after autologous stem cell transplant: pathologic analysis and comparison with de novo diffuse large B-cell lymphoma
Leukemia and Lymphoma, 10/30/09 Relevance Score: 98%

Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach
Hematological Oncology, 10/27/09 Relevance Score: 98%

Immuno-Fluorescence In Situ Hybridization Index Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A GELA Study
Journal of Clinical Oncology, 10/02/09 Relevance Score: 98%